Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders: A Prospective Randomized Control Trial

Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders: A Prospective Randomized Control Trial

Background: While combined oral contraceptives (COCs) are commonly used to treat polycystic ovary syndrome (PCOS), comparative data regarding metabolic effects of different progestogens on this patient population are missing. This study aimed to compare the different effects of drospirenone (DRP)-co...

Full description

Bibliographic Details
Main Authors: Qiu-Yi Wang, Yong Song, Wei Huang, Li Xiao, Qiu-Shi Wang, Gui-Mei Feng
Format: Article
Language:English
Published: Wolters Kluwer 2016-01-01
Series:Chinese Medical Journal
Subjects:
Cyproterone Acetate; Drospirenone; Metabolic Disorder; Oral Contraceptives
Combined; Polycystic Ovary Syndrome
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=8;spage=883;epage=890;aulast=Wang

Internet

http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=8;spage=883;epage=890;aulast=Wang

Similar Items